These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 9918214)

  • 21. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
    Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
    Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S; Datta K; Mukhopadhyay D
    Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance].
    Liu DB; Chen KN; Cao XZ; Wang T
    Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma.
    Kawahara N; Ono M; Taguchi K; Okamoto M; Shimada M; Takenaka K; Hayashi K; Mosher DF; Sugimachi K; Tsuneyoshi M; Kuwano M
    Hepatology; 1998 Dec; 28(6):1512-7. PubMed ID: 9828214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.
    Fontanini G; Boldrini L; Chinè S; Pisaturo F; Basolo F; Calcinai A; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Br J Cancer; 1999 Jan; 79(2):363-9. PubMed ID: 9888482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
    Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T
    Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
    Linderholm BK; Lindahl T; Holmberg L; Klaar S; Lennerstrand J; Henriksson R; Bergh J
    Cancer Res; 2001 Mar; 61(5):2256-60. PubMed ID: 11280795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
    Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.
    Bouvet M; Ellis LM; Nishizaki M; Fujiwara T; Liu W; Bucana CD; Fang B; Lee JJ; Roth JA
    Cancer Res; 1998 Jun; 58(11):2288-92. PubMed ID: 9622060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
    Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC
    Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.
    Li XM; Tang ZY; Zhou G; Lui YK; Ye SL
    J Exp Clin Cancer Res; 1998 Mar; 17(1):13-7. PubMed ID: 9646228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.
    West AF; O'Donnell M; Charlton RG; Neal DE; Leung HY
    Br J Cancer; 2001 Aug; 85(4):576-83. PubMed ID: 11506499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
    Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G
    Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers.
    Linderholm B; Karlsson E; Klaar S; Lindahl T; Borg AL; Elmberger G; Bergh J
    Eur J Cancer; 2004 Nov; 40(16):2417-23. PubMed ID: 15519514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.